Status:
COMPLETED
fMRI Cholinergic Mechanisms in Schizophrenia
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Schizophrenia
Eligibility:
All Genders
18-60 years
Brief Summary
This study aims to determine how clozapine treatment improves neuronal measures of sensory gating in subjects with schizophrenia.
Detailed Description
This study will use functional magnetic resonance imaging (fMRI) to study patients treated with risperidone, a commonly used neuroleptic that does not improves sensory gating, to those treated with cl...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia
- age 18-60 yrs
Exclusion
- claustrophobia
- weight \> 250 lbs
- metal in body other than dental fillings
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01191827
Start Date
October 1 2008
End Date
December 1 2011
Last Update
May 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Eastern Colorado Health Care System, Denver
Denver, Colorado, United States, 80220